Title:
ORAL PREPARATION CONTAINING CAFFEIC ACID ESTER AND BREVISCAPINE, AND PREPARATION METHOD THEREFOR
Document Type and Number:
WIPO Patent Application WO/2022/143514
Kind Code:
A1
Abstract:
The present invention relates to an oral preparation containing a caffeic acid ester and breviscapine, and a preparation method therefor and an application thereof, comprising common oral dosage forms such as capsules, tablets, oral liquid, dripping pills or granules. The preparation process provided by the present invention fully utilizes caffeic acid ester components in Erigeron breviscapus and reduces the content of other harmful and noneffective substances, and can allow for salt formation of breviscapine and the caffeic acid ester, thereby improving efficacy, having an antitumor effect while protecting liver, and providing a modern traditional Chinese medicine for clinical treatment which is more convenient and effective and more controllable in quality.
More Like This:
Inventors:
LIN YANHE (CN)
Application Number:
PCT/CN2021/141596
Publication Date:
July 07, 2022
Filing Date:
December 27, 2021
Export Citation:
Assignee:
YUNNAN BIOVALLEY PHARMACEUTICAL CO LTD (CN)
International Classes:
A61K36/28; A61P1/16; A61P3/06; A61P9/00
Foreign References:
| CN104586911A | 2015-05-06 | |||
| CN1476842A | 2004-02-25 | |||
| CN101829174A | 2010-09-15 | |||
| CN104523735A | 2015-04-22 | |||
| CN1616381A | 2005-05-18 |
Attorney, Agent or Firm:
BEIJING DIJIN INTELLECTUAL PROPERTY AGENCY LAW OFFICE (CN)
Download PDF: